Literature DB >> 27150181

Left Atrial Appendage Closure for Stroke Prevention: Devices, Techniques, and Efficacy.

Sandia Iskandar1, James Vacek1, Madhav Lavu1, Dhanunjaya Lakkireddy2.   

Abstract

Left atrial appendage closure can be performed either surgically or percutaneously. Surgical approaches include direct suture, excision and suture, stapling, and clipping. Percutaneous approaches include endocardial, epicardial, and hybrid endocardial-epicardial techniques. Left atrial appendage anatomy is highly variable and complex; therefore, preprocedural imaging is crucial to determine device selection and sizing, which contribute to procedural success and reduction of complications. Currently, the WATCHMAN is the only device that is approved for left atrial appendage closure in the United States.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Endocardial left atrial appendage closure devices; Hybrid endocardial-epicardial left atrial closure devices; Left atrial appendage closure devices; Percutaneous approach; Surgical approach

Mesh:

Year:  2016        PMID: 27150181     DOI: 10.1016/j.ccl.2015.12.009

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  3 in total

1.  Non-Pharmacologic Approach to Prevent Embolization in Patients with Atrial Fibrillation in Whom Anticoagulation is Contraindicated.

Authors:  Munish Sharma; Koroush Khalighi
Journal:  Clin Pract       Date:  2017-01-18

2.  Successful percutaneous left atrial appendage occlusion for atrial fibrillation in a patient with mirror-image dextrocardia: a case report.

Authors:  Jizhe Xu; Gaxue Jiang; Lu Zhang; Zixian Chen; Hao Wang; Ming Bai; Jie Zeng
Journal:  BMC Cardiovasc Disord       Date:  2022-01-29       Impact factor: 2.298

3.  Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation.

Authors:  Xiaoye Li; Xiaochun Zhang; Qinchun Jin; Ying Xue; Wenjing Lu; Junbo Ge; Daxin Zhou; Qianzhou Lv
Journal:  Front Pharmacol       Date:  2021-06-18       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.